Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment-Reference-Cited by-同舟云学术

Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment

Published:2024-04-20 Issue:5 Volume:17 Page:565-574
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Chuang Ling-Hsiang,Zhang Huanlan,Hong Tianqi,Xie Shitong^ORCID

Funder

National Natural Science Foundation of China

Haisco Pharmaceutical Group

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40271-024-00694-7.pdf

Reference29 articles.

1. Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. Br Med J (Clinical research ed). 2020;369: m997.

2. A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China (author's transl). Zhonghua nei ke za zhi. 1981;20(11):678–83.

3. Tang X, Yan X, Zhou H, Yang X, Niu X, Liu J, et al. Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes. Diabetes Metab Syndr Obes. 2019;12:1527–41.

4. Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes. 2021;13(4):315–409.

5. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia. 2004;47(10):1747–59.